Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gram-negative Bacterial Infection”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Study completedNCT00610168
What this trial is testing

Immunogenicity & Reactogenicity of Boostrix 10 Years After Previous Booster Vaccination.

Who this might be right for
Acellular PertussisTetanusDiphtheria
GlaxoSmithKline 82
Large-scale testing (Phase 3)Study completedNCT00262106
What this trial is testing

Trial to Evaluate PRO 2000/5 Gels for the Prevention of Vaginally Acquired HIV Infection

Who this might be right for
HIV InfectionsGonorrheaChlamydial Infections+1 more
Endo USA Inc., a Keenova Therapeutics Company 9,404
Not applicableStudy completedNCT00970749
What this trial is testing

Antigen-Specific Cell Mediated Immune Response to Chlamydia Trachomatis

Who this might be right for
Chlamydia
University of Pittsburgh 55
Post-approval studies (Phase 4)Not Yet RecruitingNCT07457385
What this trial is testing

Congenital Syphilis Treatment Trial (CONSISTENT) in Neonates

Who this might be right for
Syphilis, Congenital
University of Alabama at Birmingham 374
Not applicableStudy completedNCT02007343
What this trial is testing

Burden of Antibiotic Resistance in Gram-Negative Infections in Dutch Hospitals

Who this might be right for
Infection Resistant to DrugsGram-Negative Bacterial Infection
UMC Utrecht 3,895
Not applicableActive Not RecruitingNCT06927843
What this trial is testing

Investigational Study to Evaluate the DPP® Syphilis Screen & Confirm Antibody Point-of-care Test (POCT) to Diagnose Infectious Syphilis

Who this might be right for
Syphilis
University of Manitoba 600
Testing effectiveness (Phase 2)Study completedNCT01035853
What this trial is testing

Sino-nasal Inhalation of Colistin in Patients With Cystic Fibrosis and Pseudomonas Aeruginosa Colonization

Who this might be right for
Cystic FibrosisPseudomonas Aeruginosa
University of Jena 10
Post-approval studies (Phase 4)Study completedNCT00609375
What this trial is testing

Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen

Who this might be right for
SepsisBacteremia
Javeriana University 30
Testing effectiveness (Phase 2)Study completedNCT00258856
What this trial is testing

Persistence of Antibodies in Children Aged 7 to 15 Years Who Previously Received One Dose of Menactra® or Menomune®

Who this might be right for
MeningitisMeningococcal Infection
Sanofi Pasteur, a Sanofi Company 234
Testing effectiveness (Phase 2)Study completedNCT07624175
What this trial is testing

Immunogenicity and Tolerability of Booster Typhoid Conjugate Vaccine (TCV) 5-6 Years After Initial Dose in Children in Burkina Faso

Who this might be right for
Typhoid
Kathleen Neuzil 147
Not applicableStudy completedNCT06141837
What this trial is testing

Pseudomonas Aeruginosa Infections Among COVID-19 Patients in Intensive Care Units at CHRU of Nancy (Pyo-COVID-3)

Who this might be right for
Pseudomonas AeruginosaCOVID-19
Central Hospital, Nancy, France 51
Post-approval studies (Phase 4)Ended earlyNCT04673175
What this trial is testing

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Who this might be right for
PneumoniaHematologic MalignancyPseudomonas Aeruginosa Infection+2 more
Weill Medical College of Cornell University 17
Not applicableUnknownNCT00894036
What this trial is testing

The Burden and Genetic Variability of Extended-Spectrum ß-Lactamase (ESBL) - Producing Pathogens in Swiss Children

Who this might be right for
Enterobacteriaceae Infections
University Hospital, Geneva 100
Post-approval studies (Phase 4)Looking for participantsNCT07236944
What this trial is testing

Pivmecillinam as Oral Step-Down Treatment for Escherichia Coli Febrile Urinary Tract Infection Versus Standard of Care

Who this might be right for
Febrile Urinary Tract Infection
Uppsala University 560
Not applicableStudy completedNCT06007326
What this trial is testing

A Multicentre, Retrospective Study of Clinical Characteristics and Long-term Outcomes of Patients With Brucellosis

Who this might be right for
Brucellosis
Qin Ning 200
Not applicableStudy completedNCT05307991
What this trial is testing

Integrating Enhanced HIV PrEP Into a STI Clinic in Lilongwe

Who this might be right for
HIV InfectionsSexually Transmitted DiseasesBlood-Borne Infections+9 more
University of North Carolina, Chapel Hill 249
Early research (Phase 1)UnknownNCT02878291
What this trial is testing

Safety Study of Meningococcal ACYW135 Polysaccharide Conjugate Vaccine in Healthy Volunteers Aged Above 3 Months

Who this might be right for
Meningitis, Meningococcal
Beijing Zhifei Lvzhu Biopharmaceutical Co., Ltd 200
Early research (Phase 1)Looking for participantsNCT06559618
What this trial is testing

Bacteriophage Therapy in Spinal Cord Injury Patients With Bacteriuria

Who this might be right for
BacteriuriaSpinal Cord InjuriesAsymptomatic Bacteriuria+1 more
Barbara Trautner 30
Large-scale testing (Phase 3)Study completedNCT02428491
What this trial is testing

Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth

Who this might be right for
DiphtheriaTetanusPertussis+3 more
Sanofi Pasteur, a Sanofi Company 354
Not applicableStudy completedNCT04547413
What this trial is testing

STI/HIV Intervention Behavioral Intervention Program

Who this might be right for
Sexually Transmitted Infections
Madigan Army Medical Center 155
Next Page